Navigation Links
New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy
Date:2/7/2008

INTELENCE should be discontinued and appropriate therapy

initiated if severe rash develops

-- In general, in clinical trials, rash was mild to moderate, occurred

primarily in the second week of therapy, and was infrequent after

Week 4. Rash generally resolved within 1-2 weeks on continued therapy.

Discontinuation rate due to rash was 2 percent

-- Redistribution and/or accumulation of body fat have been observed in

patients receiving antiretroviral (ARV) therapy. The causal

relationship, mechanism, and long-term consequences of these events

have not been established

-- Immune reconstitution syndrome has been reported in patients treated

with ARV therapy, including INTELENCE

-- INTELENCE should be used with caution in patients with severe hepatic

impairment (Child-Pugh Class C) as pharmacokinetics of INTELENCE have

not been evaluated in these patients

-- The most common adverse events (>10 percent) of any intensity that

occurred at a higher rate than placebo at 24-weeks were rash (16.9

percent vs. 9.3 percent) and nausea (13.9 percent vs. 11.1 percent)

-- The most common treatment-emergent adverse reactions (Grade 2-4) that

occurred in patients receiving an INTELENCE-containing regimen vs.

placebo at 24-weeks were rash (9.0 percent vs. 3.1 percent), diarrhea

(5.2 percent vs. 9.6 percent), nausea (4.7 percent vs. 3.5 percent),

fatigue (3.3 percent vs. 4.0 percent), abdominal pain (3.0 percent vs.

2.5 percent), peripheral neuropathy (2.8 percent vs. 1.8 percent),

hypertension (2.8 percent vs. 2.2 percent), headache (2.7 percent vs.

4.1 percent), and vomiting (2.3 percent vs. 2.0 percent).

Drug Interactions

-- INTELENCE should not be co-administered with the following ARVs:

tipranavir/ritonavir, fosamprenavir/ritonavir, atazanavir/riton
'/>"/>

SOURCE Tibotec Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
2. CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
3. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
4. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
5. Chroma Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
6. Vanda Presents Phase III Iloperidone Efficacy Data
7. Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting
8. TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
10. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
11. Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- Inc. ... for the third straight year, No. 349 in ... exclusive ranking of the nation,s fastest-growing private companies. ... the most important segment of the economy—America,s independent ... Domino,s Pizza, LinkedIn, Zillow, and many other well-known ...
(Date:8/21/2014)... Kan. , Aug. 21, 2014 /PRNewswire-iReach/ -- ... Trust Alliance (HITRUST) under its Common Security Framework ... Enterprise Security and Privacy Manager, "We appreciate this ... level of commitment that this certification signifies. Our ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s ...
(Date:8/21/2014)... -- Zacks.com announces the list of stocks featured in the Analyst ... latest news and events impacting stocks and the financial markets. ... HPQ - Free Report ), IBM (NYSE: IBM - ... Free Report ), GlaxoSmithKline plc (NYSE: GSK - Free ... Free Report ). Today, Zacks is promoting its ...
Breaking Medicine Technology:Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3ScriptPro Achieves HITRUST Certification 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
(Date:8/22/2014)... 2014 Top 10 Best SEO ... hosting companies and highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ... manager of Top 10 Best SEO Hosting states, ... server hosting supplier. Actually, these companies have outperformed ... and customer support. People can get the best ...
(Date:8/22/2014)... With the stage set for the ... Expo - which will be held in Boston August ... in its online opinion section, Podium. The op-ed ... co-authored by Steven C. Anderson, IOM, CAE, president & ... the MCPHS University School of Pharmacy – Worcester/Manchester. ...
(Date:8/22/2014)... Norton HealthDay Reporter ... number of Americans on work disability chronically use powerful ... found that between 2007 and 2011, about 44 percent ... prescribed narcotic painkillers each year. And the percentage using ... to 23 percent in 2011. Experts said ...
(Date:8/22/2014)... 2014 Millennium Treatment Group, a ... FL, recently launched a new website. Patients, parents, ... can now find Millennium Treatment Group at ... live at the beginning of July. Everything anyone ... be found on the website. There’s an About ...
(Date:8/22/2014)... time an oncogenic somatic mutation at amino acid 918 ... identified in small cell lung cancer (SCLC) tumors and ... produced increased intracellular signaling and cell growth. , SCLC ... 15% of all lung cancers and is strongly associated ... has been extensively examined for genomic alterations and targeted ...
Breaking Medicine News(10 mins):Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Millennium Treatment Group Has a New Website 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2
... Brokerage Partners,announces three additional carrier approved premium finance ... National Finance,Inc. ("UNF"). These premium finance programs are ... methods for transacting,business., The benefits of these ... end with the agents, but extend to their ...
... (Nasdaq: QGLY ) today reported net sales from ... March 31, 2008,compared to $6.1 million reported for the ... 2008 reflects a net sales decrease for the,Company,s Cold ... quarter,of 2007. The change during 2008 as compared to ...
... to Receive This Season are Those That Give Back and Support ... the Fight Against AIDS in Africa, ... Day festivities a few weeks early at the INSPI(RED) Mothers,Brunch in New ... Christensen, Liya Kebede, Mya, and other (RED) supporters,to celebrate motherhood and to ...
... Association urges Senators Boxer and Feinstein to quickly pass,companion ... April 23 AARP thanked,the supporters and cosponsors of ... passed today in the U.S. House of Representatives. The ... by stopping,harmful cuts proposed by the administration., "Today,s ...
... Restated Financial Statements Filed for First Quarter and Second Quarter ... and Full Years 2005 and 2006 - - Company to Hold ... Full-year 2007 revenue of $290.9 million, up 18.7% - ... Guidance, WARSAW, Ind., April 23 Symmetry Medical Inc.,(NYSE: SMA ), a ...
... pass companion,bill and send measure to President, HARRISBURG, ... of the Protecting the Medicaid Safety Net Act of,2008, ... The bill,prevents massive increases in costs for people in ... "Today,s vote is a victory for all Pennsylvanians who ...
Cached Medicine News:Health News:Life Brokerage Partners Strengthens Premium Finance Programs 2Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 2Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 3Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 4Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 5Health News:Get INSPI(RED) This Mother's Day 2Health News:Get INSPI(RED) This Mother's Day 3Health News:Get INSPI(RED) This Mother's Day 4Health News:AARP Thanks California's Representatives for Supporting Bill to Protect People in Medicaid 2Health News:Symmetry Medical Reports Full Year 2007 Financial Results 2Health News:Symmetry Medical Reports Full Year 2007 Financial Results 3Health News:Symmetry Medical Reports Full Year 2007 Financial Results 4Health News:Symmetry Medical Reports Full Year 2007 Financial Results 5Health News:Symmetry Medical Reports Full Year 2007 Financial Results 6Health News:Symmetry Medical Reports Full Year 2007 Financial Results 7Health News:Symmetry Medical Reports Full Year 2007 Financial Results 8Health News:Symmetry Medical Reports Full Year 2007 Financial Results 9Health News:AARP Thanks Pennsylvania Representatives for Supporting Bill to Protect People in Medicaid 2
An enzyme linked immunosorbent assay (ELISA) for the detection and quantitationof RF IgG isotype in human serum of patients with rheumatoid arthritis....
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
Medicine Products: